SEC Comment Letter for CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869) (CAPR) — Mar 24, 2011

CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869)
Date: March 24, 2011 · CIK: 0001133869 · Accession: 0000000000-11-018258

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-34058

Date

March 24, 2011

Author

Jeffrey Riedler

Form

UPLOAD

Company

CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869)

Letter

March 24, 2011 Daron Evans Chief Financial Officer Nile Therapeutics, Inc. 4 West 4th Avenue, Suite 400 San Mateo, CA 94402

Re: Nile Therapeutics, Inc. Preliminary Proxy Statement on Schedule 14 A Filed March 15 , 2011 File No. 001-34058

Dear Mr. Evans :

We have comp leted our review of your filing and do not have any further comments at this time .

Sincerely,
Jeffrey Riedler
Assistant Director

Show Raw Text

March 24, 2011

Daron Evans
Chief Financial  Officer
Nile Therapeutics, Inc.
4 West 4th Avenue, Suite 400
San Mateo, CA  94402

Re: Nile Therapeutics, Inc.
  Preliminary Proxy  Statement on Schedule 14 A
Filed  March 15 , 2011
  File No.  001-34058

Dear Mr. Evans :

We have comp leted our review of your filing  and do not have any further comments at
this time .

Sincerely,

Jeffrey Riedler
Assistant Director

SecProbe.io